Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Eisai, Inc., Novartis Pharmaceuticals Corporation, and Pfizer.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

17th Annual International Congress on the Future of Breast Cancer® West

17th Annual International Congress on the Future of Breast Cancer® West


The Westin San Diego Gaslamp Quarter
910 Broadway Circle
San Diego, CA 92101
Phone: (619) 239-2200
Book Online

 


 

Overview

The 17th Annual International Congress on the Future of Breast Cancer® West serves as an update on advances in the breast cancer field, with a focus on the clinical implications of breast cancer genetic and phenotypic subtyping. Novel agents, strategies, and improved regimens are changing the future of breast cancer therapy, and these advances and their clinical impact are highlighted throughout the program. Current controversies in the field are also addressed and debated and new data presented, along with information about how to optimally individualize breast cancer therapy. This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other healthcare professionals to learn from and interact with international leaders in the field of breast cancer in order to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Eisai, Inc., Novartis Pharmaceuticals Corporation, and Pfizer.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate.

Learning Objectives

  • Individualize treatment planning for patients with breast cancer based on the appropriate use and interpretation of biomarker results and molecular or genomic assays
  • Delineate best practices in surgery and radiation therapy in order to optimize locoregional control in patients with early-stage or locally advanced breast cancer
  • Integrate recent clinical trial evidence into personalized treatment strategies for the management of patients with breast cancer
  • Discuss emerging data regarding investigational approaches for managing breast cancer in the context of evolving treatment paradigms
  • Identify variances in care and planned/ongoing clinical trials that are evaluating investigational approaches in breast cancer treatment settings breast cancer


Program Co-Chairs

Sara Hurvitz, MD
Director, Breast Cancer Clinical Research Program
Co-Director, Santa Monica – UCLA Outpatient Hematology/Oncology Practice
Associate Professor of Medicine, Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Santa Monica, CA

Joyce O'Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor Charles A. Sammons Cancer Center
Texas Oncology
Co-Chair, Breast Cancer Research Program,
The US Oncology Network
Dallas, TX







Become a Member

Forgot Password?
Filter By